Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study

ConclusionIn all subgroups, regardless of prior preventive treatment failure type, eptinezumab demonstrated greater reductions in MMDs and higher MRRs compared with placebo.Trial RegistrationClinicalTrials.gov (Identifier: NCT04418765).
Source: Neurology and Therapy - Category: Neurology Source Type: research